发明名称 T-cell mediated immunity.
摘要 The present invention provides a method of modifying the T-cell population makeup or increasing the number of T-cells in a subject having depressed or abnormal T-cell population or function, the method comprising disrupting sex steroid signalling to the thymus in the subject. The invention can be used to treat a subject suffering from a wide array of diseases, for example, cancer, HIV infection, autoimmunity and hypersensitivity. In addition, the present invention provides methods for enhancing an immune response to an antigen, treating an autoimmune disease, and decreasing a host-vs-graft reaction in a transplantation donor.
申请公布号 ZA200108451(B) 申请公布日期 2003.01.15
申请号 ZA20010008451 申请日期 2001.10.15
申请人 MONASH UNIVERSITY 发明人 RICHARD LENNOX BOYD
分类号 A61K38/09;A61K31/167;A61K31/445;A61K38/00;A61K38/04;A61K39/00;A61K39/39;A61K45/00;A61P5/02;A61P5/24;A61P15/00;A61P31/18;A61P35/00;A61P37/04;A61P37/06 主分类号 A61K38/09
代理机构 代理人
主权项
地址